Farhad Hafezi

The Narayana Nethralaya Hospital in Bangalore, India has become a leader in the field of corneal cell biology in the past 5 years
The ELZA founder Farhad Hafezi has been voted by his peers onto the Powerlist 2018, a list of the 100 top most influential people in ophthalmology.
The ELZA Institute was represented at the 2018 Meeting of the Moroccon Cataract and Refractive Surgeons in Tanger
Fifteen years into the clinical application of corneal cross-linking, we are collecting a growing number of long-term results from patients
The ELZA Institute looks back at a successful 2017 in clinics, research and education
ELZA participates at the 2017 meeting of the Cornea Society of India.
Keratoconus affects about 1 in 2,000 people in the general population, but 1 in 7 Down syndrome individuals are affected
With 10’000 participants, ESCRS has become one of the largest ophthalmological congresses in the world.
ELZA was present at EUCornea 2017 with a debate in Focus Session 5, where Farhad Hafezi from ELZA and Frank Larkin from Moorfields debated the pros and cons of PACK-Cross-Linking
Categories: |
Farhad Hafezi becomes visiting professor at one of China’s largest university eye clinics
.
.